RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial. #lymphoma #lymsm https://t.co/HlZDVQ35pD
2,454 followers
640 followers
RT @UoS_Medicine: The @SouthamptonCTU RiVa trial (RiVa – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell mal…
4,220 followers
The @SouthamptonCTU RiVa trial (RiVa – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomised controlled trial) has had a protocol paper published in Trials. Read more: https://t.co/Dyi
2,227 followers
RT @SouthamptonCTU: Protocol published for RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignanci…